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Abstract
Objective This study was to investigate the role of Nrf2/
ARE signaling pathway in the pleiotropic neuroprotective
effect of progesterone (PROG) on traumatic brain injury
(TBI).
Methods The Nrf2-knockout (Nrf2-/-) and C57 mice
were respectively subjected to a lateral cortical impact
injury caused by a free-falling object and randomly divided
into three groups: sham-operated, trauma, and trauma +
PROG treatment group. The PROG treatment group was
given PROG (32 mg/kg of body weight, intraperitoneal
injection) immediately after injury. For all groups, a series
of brain samples were obtained after trauma at 24 and 72 h,
respectively. The cerebral edema was evaluated; the
expression of IL-1b, IL-6, and TNF-a was measured using
ELISA array, and the apoptosis index was detected by
TUNEL. Flow cytometry was used to detect the intracel-
lular calcium concentration.
Results The water content, the apoptosis index, the levels
of inflammatory cytokine, and the intracellular calcium ion
were significantly decreased with the PROG treatment in
C57 mice with TBI model. However, the effect of PROG
on TBI was not found in the Nrf2-/- mouse model of
TBI.
Conclusions PROG reduced cerebral edema, apoptosis,
inflammatory reaction, and intracellular calcium ion over-
load effects after TBI. These beneficial effects were not
seen in the Nrf2-/- mouse model of TBI. The results from
this study suggested that the Nrf2/ARE signal pathway may
be involved in the pleiotropic neuroprotective effect of
PROG on TBI.
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Traumatic brain injury (TBI) is a leading cause of mor-
bidity and mortality in young adults, resulting in large
direct and indirect social loss [1]. TBI is caused by both
primary injury due to the initial biomechanical effects force
on brain tissues and subsequent secondary injury due to
activation of several pathophysiologic cascades. Brain
damage and dysfunction after TBI have been attributed to a
large extent to the secondary neurological injury mecha-
nisms. It is recognized that the pathophysiology of
secondary brain injury is a complex cascade of molecular
and biochemical events after the onset of insult, such as
neuronal excitotoxicity [2, 3], intracellular Ca2+ influx [4],
free radicals, and lipid peroxidation [5, 6], exacerbated
inflammatory response [7, 8], or subsequent neuronal cell
death via necrosis and apoptosis [9, 10].
Research has shown that progesterone (PROG) has
substantial pleiotropic properties as a neuroprotective agent
in both animal models and humans [11, 12]. PROG
attenuates glutamate excitotoxicity [13], modulates apop-
totic pathways [14], reduces membrane lipid peroxidation
[15], and limits inflammation after TBI [16]. PROG is
synthesized by oligodendrocytes and some neurons in the
brains of both sexes [17, 18]. PROG receptor is widely
expressed in the central nervous system, so various brain
regions are the normal targets of PROG [19]. PROG can
also elicit its neuroprotective effects via non-genomic
mechanisms such as through the activation of signal
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transduction pathways. Those second signal transduction
systems are known to be activated by PROG include
cAMP/PKA [20], MAPK (ERK1/2) [21, 22], TLRs/NF-jB
[23], and the PI-3K/Akt signaling pathway [17]. Activation
of such signaling pathways indicates its neuroprotective
effects on brain injury. However, the various pathways that
mediate simultaneously the pleiotropic neuroprotective
effect of PROG on TBI are still unclear.
Nuclear factor erythroid-2p45-related factor 2 (Nrf2) is
the family of transcription factors and binds antioxidant
response element (ARE) in the promoter regions of
antioxidant genes and phase II detoxification enzymes,
which has been reported to be a pleiotropic regulator in the
cellular defense mechanisms [24, 25]. Under basal condi-
tions, Nrf2 is localized within the cytoplasm by binding to
the cytosolic regulatory protein Keap1. Following activa-
tion, Nrf2 translocates to the nucleus where it binds to
ARE, and enables gene transcription [26].
Despite the demonstrated role of PROG in neuropro-
tection on TBI, none of the previous studies focused on the
Nrf2/ARE signaling pathway in relation to TBI. We
hypothesized that the effect of PROG on activating the
Nrf2/ARE signaling pathway was the mechanism whereby
PROG provides the pleiotropic neuroprotective effect on
TBI. The aim of this study was to investigate whether




A total of 36 C57 mice (obtained from Hangzhou Normal
University, Hangzhou, China), weighing 25 ± 2 g, were
housed four to a cage in air-filtered, temperature-controlled
units with 12-h light/dark cycle and regular food and water
supply. Breeding pairs of 36 Nrf2--deficient ICR mice
were obtained from Nanjing Qingzhilan Techonolgy Co.,
Ltd (Nanjing, China). Homozygous wild-type Nrf2+/+
mice and Nrf2-/--deficient mice were generated from
inbred heterozygous Nrf2+/- mice [27]. Genotypes of
Nrf2-/- and Nrf2+/+ mice were confirmed by poly-
merase chain reaction amplification of genomic DNA
isolated from the blood. PCR amplification was performed
using three different primers, 50-TGGACGGGACTATT-
GAAGGCTG-30 (sense for both genotypes), 50-
CGCCTTTTCAGTAGATGGAGG-30 (antisense for wild-
type), and 50-GCGGATTGACCGTAATGGGATAGG-30
(antisense for LacZ). The study protocol was approved by
the Committee of Animal Care and Use for Research and
Education (CACURE) of the Affiliated Hospital of Hang-
zhou Normal University and complied with the National
Institutes of Health (NIH) guidelines for the care and use of
laboratory animals.
Models of Cortical Contusion Trauma
All mice were anesthetized with pentobarbital sodium
(60 mg/kg) through intraperitoneal injection and fixed on a
stereotaxic instrument. The skin of the right hemisphere
was opened to expose the skull, a hole was drilled into the
skull at the level of the parietal cortex (2 mm to the
lambda, 2 mm to the fontanel, and 2 mm to the sagittal
suture), and the exposed dura was kept intact. Trauma was
induced by a modification of the Feeney’s weight-drop
model [28] in which a free-falling weight drops onto the
exposed intact cranial dura to produce a standardized
parietal contusion (weighing 20 g, falling from 12 cm
height). After trauma, the skull hole is closed with bone
wax and the scalp was sutured. The sham-operated mice
underwent the same surgical procedure without being
exposed to percussion injury.
Experimental Protocol
The mice were randomly assigned to three groups: (1)
sham-operated group (sham); (2) trauma group (TBI); and
(3) trauma + PROG treatment group (TBI + PROG).
PROG (purchased from Xianju Pharmaceutical Co., Ltd,
China) dissolved in 50 % dimethyl sulphoxide (10 mg/ml)
and 50 % saline was immediately given as an intraperi-
toneal injection in TBI + PROG group after trauma
(32 mg/kg body weight). Both sham and TBI groups
received the same volume/weight of vehicle injection only.
The mice were killed by decapitation at 24 and 72 h,
respectively, after injury.
Brain Tissue Water Content Measurement
A part of the mice brain (about 5 mm 9 5 mm 9 5 mm
tissue cubes) was excised from the parietal cortex directly
adjacent to the lesion core. The wet weight (WW) was
rapidly measured with a chemical balance. The tissue was
then dried in a desiccator oven at 100 C for 24 h to reach
constant dry weight (DW). The tissue water content was
calculated as [(WW - DW)/WW] 9 100 %.
TUNEL Labeling
The sample cortex surrounding the contusion area or sur-
rounding the parietal craniotomy in the sham group was
collected. Formalin-fixed tissue was embedded in paraffin
and sectioned at 4 lm with a microtome. The paraffin-
embedded sections were also detected for apoptotic cells
by terminal deoxynucleotidyl transferase dUTP nick-end-
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labeling (TUNEL) staining. The procedures were per-
formed according to the instructions provided with the
kit (Nanjing KaiJi Technology Development Co., Ltd).
Paraffin sections of 5 lm thick were deparaffinized, and
endogenous peroxidase was blocked by immersing the
sections in phosphate-buffered saline (PBS) containing
0.5 % H2O2 for 15 min. For proteins nuclei stripping,
tissue sections were incubated with proteinase K (20 lg/
ml) for 10 min. The sections were incubated with a
mixture of terminal deoxynucleotidyl transferase (TdT)
and reaction buffer containing digoxigenin-labeled dUTP.
Hematoxylin staining was performed followed by incu-
bation with anti-digoxigenin antibody conjugated with
peroxidase. Positive cells containing the fragmented
nuclear chromatin which is a characteristic of apoptosis
have brown-stained nuclei. The extent of brain damage
was evaluated by the apoptotic index (AI), which was
the average number of TUNEL-positive cells in each




A 3-mm coronal section was taken from the injured area
over the parietal cortex, accurately weighed, snap-frozen in
liquid nitrogen, and stored at -70 C. Frozen brain sam-
ples were homogenized in 1 mL of buffer containing
1 mmol/L of PMSF, 1 mg/L of pepstatin A, 1 mg/L of
aprotinin, and 1 mg/L of leupeptin in PBS solution (pH
7.2) with a glass homogenizer and then centrifuged at
12,000g for 20 min at 4 C. The supernatant was then
collected, and total protein was determined by the Bradford
method. The levels of inflammatory cytokines were quan-
tified using enzyme-linked immunosorbent assay (ELISA)
kits specific for rats according to the manufacturers’
instructions (Uscnk, USA). The cytokine contents in the
brain samples were expressed as picograms of antigen per
milligram of protein.
Measurement of Intracellular Free Calcium
([Ca21]i)by Flow Cytometry
The brain samples were washed twice with PBS, detached
with a 0.125 % trypsin treatment (37 C, 15 min), and
further washed three times with PBS. For [Ca2+]i detec-
tion, cell suspensions were incubated with fura-4-
acetoxymethyl ester (final concentration 5 lmol/L, Gibco,
USA) in the darkness at 37 C for 40 min. Then cell sus-
pensions were centrifuged at 1500 r/min for 5 min. After
washing once in 2 mL PBS, the cells were resuspended in
0.5 mL PBS. The fluorescence of 10 000 cells was ana-
lyzed by flow cytometry (488 nm). The relative
fluorescence intensity of Fluo-1 was used as the indication
of [Ca2+]i quantity.
Statistical Analysis
All data were presented as mean ± standard deviation.
SPSS 12.0 (SPSS Inc., Chicago, IL) was used for statistical
analysis of the data. For evaluation data, repeated-measures
analyses of variance (two-way or one-way as appropriate)
and t tests were utilized to determine statistical differences.
A Holm–Sidak method for multiple comparisons post hoc
test was used to determine data points with significant
differences. Statistical significance was inferred at
P < 0.05.
Results
Brain Tissue Water Content Measurement
As shown in Fig. 1, in C57 mice with acute brain injury
model, brain tissue water content adjacent to the lesion site
in the injured group was significantly increased when
compared to the sham group at 24 and 72 h after trauma,
while tissue water content was not increased in PROG
treatment group when compared with the sham group at
each time points after trauma. Tissue water content in the
TBI + PROG group was significantly reduced compared
to the injured group at the same time after trauma. How-
ever, in the Nrf2-/- mouse model of brain injury, there
was no statistical significance between the TBI + PROG
treatment group and the trauma group with the water
content of brain at 24 and 72 h after injury. PROG post-
injury administration did not attenuate cerebral edema after
trauma in the Nrf2-/- mouse model of TBI.
Apoptotic Index Measured by TUNEL Labeling
The number of apoptotic profiles was measured by TUNEL
staining. Similar to the brain tissue water content mea-
surement, PROG post-injury administration did not reduce
nerve cell death after trauma in the Nrf2-/- mouse model
of TBI. As shown in Fig. 2, in the C57 mouse model of
TBI, few TUNEL-positive apoptotic cells were found in
brains of the sham group. The apoptotic index in the cortex
surrounding the injured site was found to be significantly
increased compared to the sham group animals at 24 and
72 h after trauma in the TBI group. In TBI + PROG
group, when compared to the TBI group, the apoptotic
index in the cortex surrounding the injured site was sig-
nificantly decreased. However, in the Nrf2-/- mouse
model of TBI, there was no statistical significance between
the TBI + PROG treatment group and the TBI group with
294 Neurocrit Care (2017) 26:292–300
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the apoptotic index in the cortex surrounding the injured
site at 24 and 72 h after injury. These results indicated that
PROG administration following TBI leads to less cell death
in Nrf2+/+ mice but not in mice lacking the Nrf2 gene.
Multiplex Cytokine levels Quantified with ELISA
Array
Levels of cytokines IL-1b, IL-6, and TNF-a in brain
tissue lysate at 24 and 72 h after injury measured using a
commercially available ELISA array are shown in Fig. 3.
In C57 mice with TBI model, the inflammatory cytoki-
ne(IL-1b, IL-6, and TNF-a) levels in sham mice brain
tissue at each time point after injury were consistently
presented in a low background. All three measured
cytokine levels exhibited significant increases in different
time points. PROG treatment did produce significant
reductions in the injury-induced up-regulation of IL-1b,
IL-6, and TNF-a expression. However, in the Nrf2-/-
mouse model of TBI, PROG treatment did not reduce
IL-1b, IL-6, and TNF-a expression in brain tissues at 24
and 72 h after injury compared to the trauma group
animals.
[Ca21]i Measured by Flow Cytometry
As shown in Fig. 4, the flow cytometric analysis showed a
marked increase of the relative fluorescence intensity of
[Ca2+]i in the TBI group of C57 mice brain tissues at 24
and 72 h after injury. Compared to the TBI group, the
relative fluorescence intensity of [Ca2+]i in the TBI + -
PROG group at the same time points after injury was
significantly reduced. However, in the Nrf2-/- mouse
model of TBI, there was no statistical significance
between the TBI + PROG treatment group and the
trauma group with the relative fluorescence intensity of
[Ca2+]i in brain at 24 and 72 h after injury. Blockade of
TBI-induced [Ca2+]i by PROG in the C57 mice with TBI
model was not observed in the Nrf2-/- mouse model of
brain injury.
Discussion
This study examined the role of Nrf2/ARE signaling
pathway in the pleiotropic neuroprotective effect of PROG
on TBI. We found that PROG has neuroprotective prop-
erties in C57 mice with acute brain injury model. Clearly,
the mechanism of PROG in neuroprotection does not target
a single aspect of the secondary injury cascade following
TBI, but it instead works through multiple mechanisms to
enhance neural repair caused by head injury; as such,
PROG reduced cerebral edema, apoptosis, inflammatory
reaction, and intracellular calcium ion overload effects
after TBI. However, in the Nrf2-knockout mice model, our
results showed that the loss of Nrf2 in vivo lessens the
Fig. 1 Alterations in brain tissue water content adjacent to the lesion
site in sham group, TBI group, and TBI + PROG group (n = 12)
between the C57 mice and Nrf2-/- mouse model of brain injury at
24 and 72 h after injury. The right-hand side illustrates the Nrf2-/-
mouse model of TBI. The left-hand side is the C57 mouse model of
TBI. The brain tissue water content is given as the mean ± SE.
*P < 0.01 versus sham control and mP < 0.05 versus TBI vehicle-
treated injured mice
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pleiotropic protective effects of PROG on TBI, consistent
with a specific role for Nrf2/ARE signaling pathway.
Collectively, we speculated that the pleiotropic neuropro-
tective effect of PROG on TBI is related to the Nrf2/ARE
signal pathway. The results from our study confirm and
extend these previous observations and demonstrate for the
first time that post-injury administration of PROG may
activate the Nrf2/ARE signal pathway, and this may be the
mechanism underlying the pleiotropic neuroprotective
effect of PROG on TBI.
Recently, two large, multicenter, randomized, double-
blind, placebo-controlled phase III clinical trials evaluated
the effectiveness of PROG in patients with TBI. The results
from both trials revealed that application of PROG would
not be beneficial in the treatment of TBI [29, 30]. Various
factors have been proposed which may have contributed to
the failure of TBI trials to demonstrate convincing efficacy
in the TBI population. One major issue is the heteroge-
neous nature of TBI. Another reason may be that the
neuroprotective mechanisms of PROG on TBI are still
Fig. 2 TUNEL staining of (9400) of apoptotic neurons in the cortex
surrounding the injured site in sham group, TBI group, and
TBI + PROG group (n = 12) between the C57 mice and Nrf2-/-
mouse model of brain injury at 24 and 72 h after injury. The right-
hand side illustrates the Nrf2-/- mouse model of TBI. The left-hand
side is the C57 mice model of TBI. Scale bars, 50 lm. The apoptotic
index is given as the mean ± SE. *P < 0.01 versus sham control and
mP < 0.01 versus TBI vehicle-treated injured mice
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unclear. After extensive research on the treatment of PROG
in TBI over the last three decades, it is clear that PROG is a
neurosteroid that affects multiple mechanisms involved in
neuroprotection and neural repair following various types
of brain injury. These effects were associated with a
reduction in edema [31] and reduce neurogenic inflam-
mation [32]. PROG can upregulate the anti-apoptotic
version of Bcl-2 and anti-apoptotic protein ERK [33, 34].
There is evidence that PROG can reduce lipid peroxidation
[15] and attenuate neuronal excitotoxicity [13, 35, 36].
PROG can promote both central and peripheral remyeli-
nation through increasing myelin production [37–39]. In
the current study, we found that PROG administration
following TBI reduces apoptotic cell death and edema, and
inhibits neurogenic inflammation and neuronal excitotoxi-
city in the brain tissue surrounding the cortical contusion,
which was also observed by previous investigators.
PROG possesses pleiotropic neuroprotective effects that
may markedly attenuate the injury cascade associated with
TBI. However, the mechanism whereby PROG provides
the effects on TBI is entirely unclear. Recently, the Nrf2/
ARE signal pathway has been shown to play an indis-
pensable role in attenuation multiple pathophysiological
processes in brain injury, including oxidative stress, mito-
chondrial dysfunction, and inflammation. TBI can induce
Nrf2/ARE pathway activation in the brain [40]. Further-
more, activation of the Nrf2/ARE pathway by a
pharmacologic inducer is able to protect neurons in the
animal models of Parkinson’s disease, cerebral ischemia,
and intracerebral hemorrhage [41–43]. Specifically, the
promising Nrf2/ARE activator sulforaphane has been
demonstrated to protect neurons from TBI, including
blood–brain-barrier dysfunction, brain edema formation,
and cognitive deficits [44]. Another small molecule, car-
nosic acid, was shown to be neuroprotective in vivo in an
animal model of cerebral ischemia. These protective
effects of carnosic acid were also shown to be mediated by
activation of the Nrf2/ARE pathway and hence through
downstream mediators that are capable of eliciting a robust
neuroprotective effect [45].
However, none of the previous studies have focused on
the Nrf2/ARE signaling pathway in relation to the pleio-
tropic neuroprotection of PROG after TBI, despite the
demonstrated role of PROG in neuroprotection. To further
verify the causal relation between the Nrf2/ARE pathway
activation by PROG and its pleiotropic neuroprotective
effect in TBI, we used the TBI model of Nrf2-knockout
mice. In the current study, we found that the pleiotropic
neuroprotective effect of PROG on TBI reduced cerebral
edema, apoptosis, inflammatory reaction, and intracellular
calcium ion overload effects after TBI in Nrf2+/+ mice
but not in mice lacking the Nrf2 gene, confirming both the
neuroprotective action and the Nrf2 dependence of PROG
in vivo. This study revealed that the Nrf2/ARE signaling
pathway could be activated when treated with PROG. The
findings reported here suggest for the first time that the
Nrf2/ARE signal pathway may be involved in the pleio-
tropic neuroprotective effect of PROG on TBI.
Fig. 3 Changes of inflammatory mediators in sham group, TBI
group, and TBI + PROG group (n = 12) between the C57 mice and
Nrf2-/- mouse model of brain injury at 24 and 72 h after injury. The
cytokine levels are given as the mean ± SE. *P < 0.05 and
**P < 0.01 versus sham control and mP < 0.05 versus TBI
vehicle-treated injured mice
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In summary, to the best of our knowledge, this is the first
study to demonstrate an effect of PROG on the Nrf2/ARE
signaling pathway in the injured brain after TBI. The benefit
of PROG administration after TBI may be due to its salutary
effect on modulating the Nrf2/ARE signaling pathway.
However, the study only presented preliminary evidence that
PROG could exert pleiotropic neuroprotective effect against
TBI via up-regulating the Nrf2/ARE signaling pathway. The
present experimental results do not fully support this con-
clusion. Further experiments will be required to determine
whether PROG exerts its pleiotropic neuroprotective effects
via activation of Nrf2/ARE signaling pathways. This
hypothesis could be tested by determining the upstream
regulators of Nrf2/ARE, promoter binding sites, and the
downstream effector genes of PROG.
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